Argentina vs Belgium: Treatment success rate for patients treated for MDR-TB
Argentina
45.0%
in 2022
Belgium
47.0%
in 2022
Argentina rank
147th
Belgium rank
146th
Treatment success rate for patients treated for MDR-TB over time
- Argentina
- Belgium
How they compare
Belgium currently reports 47.0% against 45.0% in Argentina, a difference of 2.0%.
The two have swapped places 2 times across 12 shared years of data; in 2011 it was Belgium ahead.
Argentina ranks 147th and Belgium ranks 146th of 163 countries.
Belgium has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Belgium | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.3% | 77.1% | 48.8% | Belgium |
| 2020s | 40.3% | 50.0% | 9.7% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Argentina or Belgium?
- Belgium, at 47.0% against 45.0% in Argentina as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Argentina and Belgium?
- 2.0%, with Belgium ahead.
- How many years of comparable data are there for Argentina and Belgium?
- 12 years are reported by both, from 2011 to 2022.
- How do Argentina and Belgium rank globally for treatment success rate for patients treated for mdr-tb?
- Argentina ranks 147th and Belgium ranks 146th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.